Statement from Shaya Brodchandel, president of the New Jersey Cannabis Trade Association in Response to Today’s CRC Announcement on New Cannabis Licenses in New Jersey
Trenton, N.J. (Oct. 15, 2021) – On behalf of the New Jersey Cannabis Trade Association (NJCTA), below please find the following statement from Shaya Brodchandel, president of NJCTA and CEO of Harmony Foundation of New Jersey, in response to the New Jersey Cannabis Regulatory Commission’s (CRC) announcement today on the state’s new cannabis licenses:
“The New Jersey Cannabis Trade Association congratulates the new licensees in New Jersey’s burgeoning cannabis industry.
“Our member Alternative Treatment Centers are proud to have laid much of the groundwork as the first to serve NJ’s medical marijuana patients. We anticipate dynamic growth and development in the industry as the new entities become operational and the great potential of New Jersey’s adult-use market becomes a reality.
“Together, we have an exciting road ahead and look forward to working with these new licensees – and those to come – to continue building this growing industry.”
For more information on NJCTA, go to NJCannabisTrade.org.
About New Jersey Cannabis Trade Association
New Jersey Cannabis Trade Association (NJCTA) represents the majority of the Alternative Treatment Centers (ATCs) in New Jersey’s Medicinal Marijuana Program. Our mission is to create a legal cannabis marketplace that works for everyone by fostering an industry that is not only safe, accessible, and affordable, but also equitable and just. Formed amidst the COVID-19 pandemic and, given the gravity of the situation facing New Jersey’s growing medical marijuana patient population, NJCTA was created to provide a unified and streamlined voice for the ATCs in its interactions with the New Jersey Department of Health (DOH).